p53 and FUS1 in nanoparticles show anti-tumor efficacy in preclinical study.
D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D045744:Cell Line, Tumor; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D016158:Genes, p53; D015316:Genetic Therapy; D006801:Humans; D051379:Mice; D053758:Nanoparticles / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy*; D025521:Tumor Suppressor Proteins / Q000378:metabolism*
C499993:TUSC2 protein, human; D025521:Tumor Suppressor Proteins